StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

ENDRA Life Sciences's market cap was $7.15M on Nov 11, 2026, against $4.65M a year earlier. Over the last 5 years it ranged from $1.88M to $2.53T, with a median of $970.34M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.15M+100.6%
2025Dec 31, 2025$3.56M+6.5%
2024Dec 31, 2024$3.35M-100.0%
2023Dec 29, 2023$31.21B-93.1%
2022Dec 30, 2022$449.98B-55.9%
2021Dec 31, 2021$1.02T+55.5%
2020Dec 31, 2020$656.70B+48.6%
2019Dec 31, 2019$442.01B+113.3%
2018Dec 31, 2018$207.27B-68.8%
2017Dec 29, 2017$664.66B–

More ENDRA Life Sciences figures

See a number that looks wrong?